Table 4.

Demographic, psychopathological, and treatment features at baseline for patients with personality disorders with (N = 39) and without (n = 33) follow-up examination.

Variable	Follow-up + (n = 39)	Follow-up - (n = 33)	p
Age (mean, SD)	37.9 (11.6)	33.3 (9.9)	.08
Gender (n, %)			.50
Male	17 (44)	17 (52)
Female	22 (56)	16 (48)
Relationship (n, %)			.56
Paired	18 (46)	13 (39)
Non-paired	21 (54)	20 (61)
Basic education level (n, %)			.64
≤ 9 years	11 (29)	13 (40)
10 – 12 years	13 (34)	10 (30)
≥ 13 years	14 (37)	10 (30)
≥ 1 cluster A PDs	13 (33)	6 (18)	.15
≥ 1 cluster B PDs	10 (26)	15 (45)	.08
≥ 1 cluster C PDs	35 (90)	22 (67)	.02
Mean (SD) of PD cluster criteria
Total	34.8 (17.9)	34.8 (14.3)	.99
Cluster A	9.5 (8.7)	7.7 (5.1)	.28
Cluster B	7.6 (9.3)	13.1 (10.3)	.02
Cluster C	17.6 (8.9)	14.0 (7.2)	.07
≥ 1 depressive disorder	19 (49)	7 (21)	.02
≥ 1 anxiety disorder	17 (44)	16 (49)	.68
≥ 1 substance use disorder	9 (23)	11 (33)	.33
Comorbid Axis I disorder (n, %)			.79
No	9 (23)	9 (27)
Yes	30 (77)	24 (33)
GAF (mean, SD)	46.0 (9.4)	45.7 (9.9)	.91
PSI (mean, SD)	1.5 (.9)	1.6 (.7)	.85
SAS Overall (mean, SD)	2.7 (.6)	2.6 (.6)	.86
SF-36 (mean, SD)*
Physical Functioning	79.4 (19.1)	76.7 (22.5)	.72
Role Functioning	31.4 (34.3)	25.8 (36.2)	.27
Bodily Pain	47.6 (28.9)	48.1 (26.7)	.71
General Health	51.4 (23.5)	50.5 (20.39	.99
Vitality	35.0 (19.6)	29.1 (18.6)	.16
Social Functioning	45.2 (28.5)	48.9 (21.5)	.60
Role Emotional	42.7 (39.7)	32.3 (31.7)	.35
Mental Health	42.5 (23.2)	38.3 (19.5)	.52
No of sessions (mean, SD)*	16.6 (5.9)	18.8 (26.9)	.01
Termination without consensus (n, %)	0 (0.0)	22 (67)	< . 001
Treated by specialist (n, %)	14 (36)	16 (49)	.28
Additional drug treatment (n, %)	20 (51)	20 (61)	.43

*Mann-Whitney tests